Gemelli Biotech Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 27

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $19M

  • Investors
  • 7

Gemelli Biotech General Information

Description

Developer of medical devices designed to provide diagnostics for the human microbiome. The company uses blood tests to measure the levels of two antibodies known to be elevated in patients with post-infectious irritable bowel syndrome and also provides a breath test system that aids in the identification of small intestinal bacterial overgrowth, enabling physicians to get an optimized diagnosis protocol for diarrhea-predominant and mixed-type irritable bowel syndrome.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2020 Progress Court
  • Suite 100-101
  • Raleigh, NC 27608
  • United States
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Vertical(s)
LOHAS & Wellness, HealthTech, Life Sciences
Corporate Office
  • 2020 Progress Court
  • Suite 100-101
  • Raleigh, NC 27608
  • United States

Gemelli Biotech Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Gemelli Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series A) 08-Jun-2022 $19M Completed Generating Revenue
3. Early Stage VC (Series A) 07-Dec-2021 Completed Generating Revenue
2. Seed Round 27-Jun-2019 $1.85M $3.85M Completed Generating Revenue
1. Seed Round 27-Nov-2018 $2M $2M Completed Startup
To view Gemelli Biotech’s complete valuation and funding history, request access »

Gemelli Biotech Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A1
Series A2
Seed Plus 1,229,508 $0.000100 $2.44 $2.44 1x $2.44 6.73%
Seed 1,333,332 $0.000100 $1.5 $1.5 1x $1.5 7.3%
To view Gemelli Biotech’s complete cap table history, request access »

Gemelli Biotech Patents

Gemelli Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2021361055-A1 Microbiome-derived gaseous sample collection system and methods Pending 16-Oct-2020
CA-3195531-A1 Microbiome-derived gaseous sample collection system and methods Pending 16-Oct-2020
EP-4228797-A1 Microbiome-derived gaseous sample collection system and methods Pending 16-Oct-2020
US-20220117513-A1 Microbiome-derived gaseous sample collection system and methods Pending 16-Oct-2020
AU-2021361055-A9 Microbiome-derived gaseous sample collection system and methods Pending 16-Oct-2020 A61B10/0096
To view Gemelli Biotech’s complete patent history, request access »

Gemelli Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Gemelli Biotech Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Carolina Angel Network Angel Group Minority
Cedars-Sinai Corporation Minority
CerraCap Ventures Venture Capital Minority
LOUD Capital Venture Capital Minority
New Day Venture Capital Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Gemelli Biotech FAQs

  • When was Gemelli Biotech founded?

    Gemelli Biotech was founded in 2018.

  • Where is Gemelli Biotech headquartered?

    Gemelli Biotech is headquartered in Raleigh, NC.

  • What is the size of Gemelli Biotech?

    Gemelli Biotech has 27 total employees.

  • What industry is Gemelli Biotech in?

    Gemelli Biotech’s primary industry is Diagnostic Equipment.

  • Is Gemelli Biotech a private or public company?

    Gemelli Biotech is a Private company.

  • What is Gemelli Biotech’s current revenue?

    The current revenue for Gemelli Biotech is .

  • How much funding has Gemelli Biotech raised over time?

    Gemelli Biotech has raised $57.7M.

  • Who are Gemelli Biotech’s investors?

    Carolina Angel Network, Cedars-Sinai, CerraCap Ventures, LOUD Capital, and New Day Venture Capital are 5 of 7 investors who have invested in Gemelli Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »